Sodium butyrate promotes reassembly of tight junctions in Caco-2 monolayers involving inhibition of MLCK/MLC2 pathway and phosphorylation of PKCβ2

International Journal of Molecular Sciences

Volumn 17, Issue 10, 2016, Pages

  Miao, Wei ^a   Wu, Xiujuan ^a   Wang, Kang ^a   Wang, Wenjing ^a   Wang, Yumei ^a   Li, Zhigang ^a   Liu, Jingjing ^a   Li, Li ^a   Peng, Luying ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

(Protein kinase C ) PKC ; Butyrate; Caco 2; Myosin II regulatory light chain (MLC2); Myosin light chain kinase (MLCK); Tight junction

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; BUTYRIC ACID; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MEPENZOLATE; MYOSIN LIGHT CHAIN 2; MYOSIN LIGHT CHAIN KINASE; NICOTINIC ACID; PROTEIN KINASE C BETA; CARDIAC MYOSIN; MYOSIN LIGHT CHAIN;

ARTICLE; ASSAY; CACO 2 CELL LINE; CALCIUM CELL LEVEL; CALCIUM SWITCH ASSAY; CONTROLLED STUDY; ENTEROPATHY; ENZYME PHOSPHORYLATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTESTINE FUNCTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSEPITHELIAL RESISTANCE; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CACO-2 CELL LINE; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASES; BLOTTING, WESTERN; BUTYRIC ACID; CACO-2 CELLS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CARDIAC MYOSINS; HUMANS; IMMUNOPRECIPITATION; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION; PROTEIN KINASE C BETA; TIGHT JUNCTIONS;

EID: 84991329768     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17101696     Document Type: Article

References (43)

1. Bergman, E.N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol. Rev. 1990, 70, 567-590. [PubMed]
2. Bugaut, M. Occurrence, absorption and metabolism of short chain fatty acids in the digestive tract of mammals. Comp. Biochem. Physiol. Part B Comp. Biochem. 1987, 86, 439-472. [CrossRef]
3. Bugaut, M.; Bentejac, M. Biological effects of short-chain fatty acids in nonruminant mammals. Annu. Rev. Nutr. 1993, 13, 217-241. [CrossRef] [PubMed]
4. Gill, R.K.; Dudeja, P.K. A novel facet to consider for the effects of butyrate on its target cells. Focus on "the short-chain fatty acid butyrate is a substrate of breast cancer resistance protein". Am. J. Physiol. Cell Physiol.2011, 301, C977-C979. [CrossRef] [PubMed]
5. Harten, S.K.; Shukla, D.; Barod, R.; Hergovich, A.; Balda, M.S.; Matter, K.; Esteban, M.A.; Maxwell, P.H. Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin. Mol. Biol. Cell 2009, 20, 1089-1101. [CrossRef] [PubMed]
6. Pan, L.; Matloob, A.F.; Du, J.; Pan, H.; Dong, Z.; Zhao, J.; Feng, Y.; Zhong, Y.; Huang, B.; Lu, J. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. FEBS J. 2010, 277, 989-999. [CrossRef] [PubMed]
7. Peng, L.; Li, Z.R.; Green, R.S.; Holzman, I.R.; Lin, J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr.2009, 139, 1619-1625. [CrossRef] [PubMed]
8. Hardie, D.G.; Hawley, S.A.; Scott, J.W. AMP-activated protein kinase-Development of the energy sensor concept. J. Physiol. 2006, 574, 7-15. [CrossRef] [PubMed]
9. Hardie, D.G.; Ross, F.A.; Hawley, S.A. AMP-activated protein kinase: A target for drugs both ancient and modern. Chem. Biol. 2012, 19, 1222-1236. [CrossRef] [PubMed]
10. 2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 1995, 270, 27186-27191. [CrossRef] [PubMed]
11. Oakhill, J.S.; Steel, R.; Chen, Z.P.; Scott, J.W.; Ling, N.; Tam, S.; Kemp, B.E. AMPK is a direct adenylate charge-regulated protein kinase. Science 2011, 332, 1433-1435. [CrossRef] [PubMed]
12. 2+/calmodulin-dependent protein kinase kinase β. Mol. Cell. Biol. 2006, 26, 5933-5945. [CrossRef] [PubMed]
13. 2+/calmodulin-dependent protein kinase. J. Tongji Univ. Med. Sci. 2015, 8-12.
14. Sun, S.; Li,W.; Zhang, H.; Zha, L.; Xue, Y.;Wu, X.; Zou, F. Requirement for store-operated calcium entry in sodium butyrate-induced apoptosis in human colon cancer cells. Biosci. Rep. 2012, 32, 83-90. [CrossRef] [PubMed]
15. Maslowski, K.M.; Vieira, A.T.; Ng, A.; Kranich, J.; Sierro, F.; Yu, D.; Schilter, H.C.; Rolph, M.S.; Mackay, F.; Artis, D.; et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461, 1282-1286. [CrossRef] [PubMed]
16. Thangaraju, M.; Cresci, G.A.; Liu, K.; Ananth, S.; Gnanaprakasam, J.P.; Browning, D.D.; Mellinger, J.D.; Smith, S.B.; Digby, G.J.; Lambert, N.A.; et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009, 69, 2826-2832. [CrossRef] [PubMed]
17. Macia, L.; Tan, J.; Vieira, A.T.; Leach, K.; Stanley, D.; Luong, S.; Maruya, M.; Ian McKenzie, C.; Hijikata, A.; Wong, C.; et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 2015, 6, 6734. [CrossRef] [PubMed]
18. Anderson, J.M.; Van Itallie, C.M. Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 1995, 269, G467-G475. [PubMed]
19. Turner, J.R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009, 9, 799-809. [CrossRef] [PubMed]
20. Fanning, A.S.; Jameson, B.J.; Jesaitis, L.A.; Anderson, J.M. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 1998, 273, 29745-29753. [CrossRef] [PubMed]
21. Fanning, A.S.; Ma, T.Y.; Anderson, J.M. Isolation and functional characterization of the actin-binding region in the tight junction protein ZO-1. FASEB J. 2002, 16, 1835-1837. [CrossRef] [PubMed]
22. Cunningham, K.E.; Turner, J.R. Myosin light chain kinase: Pulling the strings of epithelial tight junction function. Ann. N. Y. Acad. Sci. 2012, 1258, 34-42. [CrossRef] [PubMed]
23. Shen, L.; Turner, J.R. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol. Biol. Cell 2005, 16, 3919-3936. [CrossRef] [PubMed]
24. Chen, C.L.; Wang, P.; Su, Q.; Wang, S.L.; Wang, F.J. Myosin light chain kinase mediates intestinal barrier disruption following burn injury. PLoS ONE 2012, 7, e34946. [CrossRef] [PubMed]
25. Zolotarevsky, Y.; Hecht, G.; Koutsouris, A.; Gonzalez, D.E.; Quan, C.; Tom, J.; Mrsny, R.J.; Turner, J.R. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 2002, 123, 163-172. [CrossRef] [PubMed]
26. Allen, C.; Srivastava, K.; Bayraktutan, U. Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction. Stroke 2010, 41, 2056-2063. [CrossRef] [PubMed]
27. Banan, A.; Fields, J.Z.; Talmage, D.A.; Zhang, Y.; Keshavarzian, A. PKC-β1 mediates EGF protection of microtubules and barrier of intestinal monolayers against oxidants. Am. J. Physiol. Gastrointest. Liver Physiol.2001, 281, G833-G847. [PubMed]
28. Seth, A.; Yan, F.; Polk, D.B.; Rao, R.K. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a pkc- and map kinase-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G1060-G1069. [CrossRef] [PubMed]
29. Singh, V.; Jamwal, S.; Jain, R.; Verma, P.; Gokhale, R.; Rao, K.V. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe 2012, 12, 669-681. [CrossRef] [PubMed]
30. Lewis, R.S. The molecular choreography of a store-operated calcium channel. Nature 2007, 446, 284-287. [CrossRef] [PubMed]
31. Steinberg, S.F. Structural basis of protein kinase C isoform function. Physiol. Rev. 2008, 88, 1341-1378. [CrossRef] [PubMed]
32. Rigor, R.R.; Hawkins, B.T.; Miller, D.S. Activation of PKC isoform β(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain. J. Cereb. Blood Flow Metab. 2010, 30, 1373-1383. [CrossRef] [PubMed]
33. Hamer, H.M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F.J.; Brummer, R.J. Review article: The role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27, 104-119. [CrossRef] [PubMed]
34. Singh, N.; Gurav, A.; Sivaprakasam, S.; Brady, E.; Padia, R.; Shi, H.; Thangaraju, M.; Prasad, P.D.; Manicassamy, S.; Munn, D.H.; et al. Activation of GPR109A, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40, 128-139. [CrossRef] [PubMed]
35. Borthakur, A.; Priyamvada, S.; Kumar, A.; Natarajan, A.A.; Gill, R.K.; Alrefai,W.A.; Dudeja, P.K. A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1. Am. J. Physiol. Gastrointest. Liver Physiol.2012, 303, G1126-G1133. [CrossRef] [PubMed]
36. Horman, S.; Morel, N.; Vertommen, D.; Hussain, N.; Neumann, D.; Beauloye, C.; El Najjar, N.; Forcet, C.; Viollet, B.; Walsh, M.P.; et al. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J. Biol. Chem. 2008, 283, 18505-18512. [CrossRef] [PubMed]
37. Lynch, J.J.; Ferro, T.J.; Blumenstock, F.A.; Brockenauer, A.M.; Malik, A.B. Increased endothelial albumin permeability mediated by protein kinase C activation. J. Clin. Investig. 1990, 85, 1991-1998. [CrossRef] [PubMed]
38. Ben-Ze’ev, A. Tumor promoter-induced disruption of junctional complexes in cultured epithelial cells is followed by the inhibition of cytokeratin and desmoplakin synthesis. Exp. Cell Res. 1986, 164, 335-352. [CrossRef]
39. Siflinger-Birnboim, A.; Goligorsky, M.S.; del Vecchio, P.J.; Malik, A.B. Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increase in endothelial permeability. Lab Investig. J. Tech. Methods Pathol.1992, 67, 24-30.
40. Garcia, J.G.N.; Aschner, J.L.; Malik, A.B. Regulation of thrombin-induced endothelial barrier dysfunction and prostaglandin synthesis. In Thrombin: Structure and Function; Berliner, L.J., Ed.; Springer US: Boston, MA, USA, 1992; pp. 397-430.
41. 2. Am. J. Physiol. 1989, 256, H1012-H1022. [PubMed]
42. Spyridopoulos, I.; Luedemann, C.; Chen, D.; Kearney, M.; Chen, D.; Murohara, T.; Principe, N.; Isner, J.M.; Losordo, D.W. Divergence of angiogenic and vascular permeability signaling by VEGF: Inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, no-dependent vascular permeability. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 901-906. [CrossRef] [PubMed]
43. Valenzano, M.C.; DiGuilio, K.; Mercado, J.; Teter, M.; To, J.; Ferraro, B.; Mixson, B.; Manley, I.; Baker, V.; Moore, B.A.; et al. Remodeling of tight junctions and enhancement of barrier integrity of the Caco-2 intestinal epithelial cell layer by micronutrients. PLoS ONE 2015, 10, e0133926. [CrossRef] [PubMed]